RESEARCH FACULTY

Yue Jin Wen, M.D., Ph.D. Instructor

M.D., Nanjing Medical University, China
Ph.D., University of Wales College of Medicine, UK
Fellowship, Hematology/Oncology, University of Wales College of Medicine, UK
Fellowship, Oncology, Shanghai Medical University, China
Assistant Professor, Physician, Division of Surgical Oncology, University Hospital of Nanjing Medical University, Nanjing, China
Research Instructor, Surgical Oncology, Pathology and Geriatrics, University of Arkansas for Medical Sciences

Selected Publications:

Wen YJ, Mancino AT, Pashov A, Whitehead T, Stanley J, and Kieber-Emmons T. (2005). Antigen binding of human IgG Fabs mediate ERK associated proliferation of human breast cancer cells. DNA Cell Biol. 24(2):73-84.

Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen YJ, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC. (2002). Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 298(5594):843-6.

Wen YJ, Min R, Tricot G, Barlogie B, Yi Q. (2002). Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy. Blood. 99(9):3280-5.

Wen YJ, Barlogie B, Yi Q. (2001). Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells. Blood. 97(6):1750-5.

Lim SH, Wen YJ, Ling M. (2000). Malignancy: Idiotypic Immune Targeting of Multiple Myeloma. Hematol. 4(6):471-477.

Having problems with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
Terms and Conditions of Use

The information on the Myeloma Institute web site is not intended as a substitute for professional medical attention. The information is intended only as an aid in understanding current medical knowledge. A physician should always be consulted for any health concern or medical condition. The Myeloma Institute web site provides links to other organizations as a service to our readers. The Myeloma Institute is not responsible for the information provided on other web sites.